Amgen (AMGN) Retained Earnings (2009 - 2026)

Amgen (AMGN) has reported Retained Earnings for 18 consecutive years, with -$190.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Retained Earnings rose 99.3% year-over-year to -$190.0 million; the TTM figure through Mar 2026 stood at -$190.0 million (up 99.3% YoY), while the FY2025 annual figure was -$258.0 million, up 99.06% from the prior year.
• Retained Earnings came in at -$190.0 million for Q1 2026 at Amgen, up from -$258.0 million in the prior quarter.
• The five-year high for Retained Earnings was -$126.0 million in Q3 2023, with the low at -$29.6 billion in Q1 2022.
• Average Retained Earnings over 5 years is -$9.8 billion, with a median of -$544.0 million recorded in 2025.
• Across the five-year window, Retained Earnings sank 20161.9% in 2024 and jumped 99.3% in 2026, its largest moves.
• Year by year, Retained Earnings stood at -$231.0 million in 2022, then slipped by 25.11% to -$289.0 million in 2023, then sank by 9446.71% to -$27.6 billion in 2024, then jumped by 99.06% to -$258.0 million in 2025, then rose by 26.36% to -$190.0 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered -$190.0 million, -$258.0 million, and -$422.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.